David Shook - 01 Jul 2023 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Medical Officer
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Issuer symbol
NKTX
Transactions as of
01 Jul 2023
Net transactions value
$0
Form type
4
Filing time
05 Jul 2023, 16:06:24 UTC
Previous filing
22 Jun 2023
Next filing
23 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTX Stock Option (right to buy) Award $0 +208,000 $0.000000 208,000 01 Jul 2023 Common Stock 208,000 $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2023.